Patterns and predictors of statin use after coronary artery bypass graft surgery
Authors:
- Raisa LevinRLRaisa Levin
- Marc RuelMRMarc Ruel
- Thierry G. MesanaTMThierry G. Mesana
- Daniel H. SolomonDSDaniel H. Solomon
- Niteesh K. ChoudhryNCNiteesh K. Choudhry
- 1 October 2007
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 134 (4) , 932-938
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Care Transitions InterventionArchives of internal medicine (1960), 2006
- Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery DiseaseCirculation, 2006
- A review of uses of health care utilization databases for epidemiologic research on therapeuticsJournal of Clinical Epidemiology, 2005
- Statins Are Associated With a Reduced Incidence of Perioperative Mortality After Coronary Artery Bypass Graft SurgeryCirculation, 2004
- Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population studyAmerican Heart Journal, 2004
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Are we negating the benefits of CABG by forgetting secondary prevention?Journal of Human Hypertension, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veinsJACC, 2000
- Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 yearsJACC, 1996